Searchable abstracts of presentations at key conferences in endocrinology

ea0085oc9.5 | Oral Communications 9 | BSPED2022

Raising awareness of the importance of preconception counselling in young people with diabetes

Green Steve , Dublon Victoria , Meso Muriel , Burchem Melanie , Beesley Avril , Ambridge Jade , Smith Madeleine

Introduction: Pregnancy under the age of 19 is considered high-risk1; and a pregnancy with diabetes at this age further increases that risk2,3. With the correct advice and counselling, these risks can be greatly reduced. Here we describe a strategy to raise awareness by addressing this as part of regular clinic visits.Method: Prior knowledge of potential complications of pregnancy was assessed as part of a clinical consultation. Evi...

ea0036oc4.3 | Oral Communications 4 | BSPED2014

A role for delta-like homologue 1 in a secretory placental population and implications for fetal growth

Meso Muriel , Katugampola Harshini , Aquilina Joe , Allen Rebecca , Marleen Shemoon , Storr Helen , Dunkel Leo , Charalambous Marika

Background: Delta-like homologue 1 (DLK1) encodes a transmembrane protein, which may also be secreted into the circulation. Levels are known to rise in maternal serum during late gestation and our genetic studies in the mouse have shown that this DLK1 arises from the conceptus. The cell population that secretes DLK1 into the maternal circulation has not been identified. In humans DLK1 has been shown to be differentially expressed in intrauterine growth restricted (IUGR) when c...

ea0033p82 | (1) | BSPED2013

The use of Radioactive Iodine in the treatment of childhood and adolescent hyperthyroidism

Meso Muriel , Storr Helen , Allgrove Jeremy , Saccaram Sonali , Newell Margaret , Drake William

Background: Treatment options for Graves’ disease (GD) and multinodular goitre include antithyroid medication, near total thyroidectomy and radioactive iodine (RAI). RAI is an established treatment for GD in the adult population but is used less commonly in children and the adolescent population due to concerns with regards to safety.Methods: A review of a series of 14 adolescent patients receiving RAI between 2007 and 2013 in our department was per...

ea0051p002 | Thyroid | BSPED2017

Radioactive Iodine therapy for the management of hyperthyroidism in children and adolescents

Wilkinson Ingrid C E Wilkinson , Meso Muriel , Rowse Victoria , Joel Emily , Morris Elizabeth , Price Leanne , Storr Helen L , Drake William M

Background: Radioactive iodine therapy (RAI) is established as a safe and effective treatment for adults with Grave’s disease. As thyrotoxicosis in children is rare, it is difficult to obtain high quality evidence about the safety and efficacy of RAI. We present data from our centre between 2007 and 2017.Methods: 20 paediatric patients with hyperthyroidism (16F), median age 15.7 years (range 10.8–19.3) had RAI in our centre either one or two do...